Classification of BHET platforms into three types based on their functional objectives: 1) tissue-sensor platforms, 2) tissue-electromodulator platforms, 3) tissue-communicator platforms. Credit: ...

BRISBANE, Calif. & EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) and Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO) – today announced an exclusive partnership aimed at ...

Add Yahoo as a preferred source to see more of our stories on Google. Intermountain Medical Center participated in a trial of the first bioengineered external liver, designed to help acute liver ...

EDEN PRAIRIE, Minn., March 29, 2022 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to ...

A phase 1 study of miroliverELAP for the treatment of acute liver failure is currently underway;1 first patient in the study underwent the procedure at Intermountain Medical Center in Murray, Utah ...

Please provide your email address to receive an email when new articles are posted on . CareDx intends to develop a testing solution to use in pre-clinical animal models. CareDx will provide ...

Presenters at the American Society of Nephrology (ASN) Kidney Week 2023 highlighted the exciting new technologies that nephrology research has developed to improve patient outcomes, quality of life, ...

Using a novel "organ-on-a-chip" model, Baker Heart & Diabetes Institute researchers have discovered a potential therapeutic target that may slow down vascular aging and reduce heart disease, kidney ...

Bioengineered organs are no longer just structural substitutes. A review published in Trends in Biotechnology introduces a groundbreaking concept: biohybrid-engineered tissue (BHET) platforms—living ...

CareDx, Inc. CDNA and Miromatrix Medical Inc. ("Miromatrix") MIRO – today announced an exclusive partnership aimed at advancing the next wave of innovation using fully transplantable human ...